Zydus Cadila gets USFDA nod for arthritis drug with 180-days exclusivity


PTI, Aug 24, 2021, 1:34 PM IST

New Delhi: Drug firm Zydus Cadila on Monday said it has received final approval from the US health regulator to market Tofacitinib extended-release tablets, used to treat rheumatoid arthritis, in the American market. The company said it has received approval from the US Food and Drug Administration (USFDA) for the drug in 11 mg and 22 mg strengths.

Zydus was the first abbreviated new drug application (ANDA) filer on Tofacitinib extended-release tablets 22 mg and thus holds 180-day exclusivity on this strength, the company said in a statement.

According to IQVIA data, Tofacitinib extended-release tablets had annual sales of around USD 2,082 million in the US for the year ending June 2021.

Zydus said it would produce the drug at the group’s formulation manufacturing facility at the SEZ, Ahmedabad.

The Zydus group now has 321 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in 2003-04, it added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Centre asks FM radio channels not to play songs glorifying drugs

Viewers flock to watch glowing lava ooze from Hawaii volcano

GST revenues rise 11 pc to Rsa 1.46 lakh cr in Nov

Belagavi: Student allegedly assaulted for dancing with Kannada flag

K’taka assembly polls 2023: Over 40 Congress aspirants in DK submit applications

Book on Chipko Movement bags Kamaladevi Chattopadhyay NIF Prize

Cong opposes decision to install Chhatrapati Shivaji statue in Mangaluru


Related Articles More

Active Covid cases in country decline to 4,767

Studies find new computational tools help in better epilepsy surgery results

Mumbai records 15 new measles cases

New single-dose drug 95 per cent effective against sleeping sickness in adults: Lancet study

Covid nasal sprays may one day prevent and treat infection

MUST WATCH

Oxygen Concentrator

Deepotsava at Shri Durga Adishakti temple

Girija Surgicals nebulizer vedio

KL Rahul Visit Kukke Subrahmanya Temple

Police commissioner N.Shahsikumar statement about viral video


Latest Additions

Centre asks FM radio channels not to play songs glorifying drugs

Viewers flock to watch glowing lava ooze from Hawaii volcano

Markets on record-making spree rally for 8th day

Kerala HC declines to interfere in PIL challenging rules for appointment of ministers’ personal staff

Obama heads to Georgia as Warnock seeks big early vote advantage

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.